NEJM 17 Oct 2013 Vol 369 1491 “Tiotropium (Spiriva, Boehringer Ingelheim), a long-acting inhaled anticholinergic bronchodilator, improves lung function, quality of life, and exercise endurance and reduces exacerbations in patients with chronic obstructive pulmonary disease (COPD).” I quote not from an advertisement for Spiriva, but from the start of a paper comparing one delivery method […]
Richard Lehman’s journal review—21 October 2013